Floatz logo

PREDNISONE TABLETS

Optic Neuritis

National Eye Institute (NEI)Small moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Optic Neuritis cohort.

Asset / SponsorPhaseRating
Interferon ?1 (human fibroblast protein moiety)
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Phase 4BB
Fampridine
Courtney Casserly
Phase 2/3BB
METHOTREXATE
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Phase 4BB
Privosegtor
Oculis
Phase 3B
SIMVASTATIN
Glostrup University Hospital, Copenhagen
Phase 3B

View all 15 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →